Lysette Ramos, MD
Child & Adolescent Psychiatry · Reading, PANPI 1336469642
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 117 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,683, more than ten times the $41 reported in 2019.
Across 117 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$354
- Otsuka America Pharmaceutical, Inc.$338
- Axsome Therapeutics, Inc.$335
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$230
- AbbVie$204
- Vanda Pharmaceuticals Inc.$185
- plus $552 from 8 others
What the payments were for
- Food & beverage$2,191100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 18 | $354 |
| Otsuka America Pharmaceutical, Inc. | 20 | $338 |
| Axsome Therapeutics, Inc. | 17 | $335 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $230 |
| AbbVie | 15 | $204 |
| Vanda Pharmaceuticals Inc. | 9 | $185 |
| Neurocrine Biosciences, Inc. | 7 | $155 |
| Lundbeck LLC | 7 | $143 |
| Corium, LLC | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $43 |
| GSK | 2 | $41 |
| E.r. Squibb & Sons, L.L.C. | 2 | $41 |
| Johnson & Johnson | 2 | $40 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
How this compares
$2,197 in reported general payments places this provider in the 80th percentile of 200 child & adolescent psychiatry providers in Pennsylvania.
See all child & adolescent psychiatry providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 13 | $3,571 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 35 | $1,283 |
| Duloxetine Hcl | 56 | $1,099 |
| Bupropion XlBupropion Hcl | 52 | $1,063 |
| Buspirone Hcl | 64 | $839 |
| Clonazepam | 62 | $775 |
| Lurasidone Hcl | 16 | $732 |
| Hydroxyzine Hcl | 52 | $687 |
| Ziprasidone Hcl | 11 | $636 |
| Lamotrigine | 37 | $455 |
| Trazodone Hcl | 62 | $352 |
| Guanfacine Hcl | 13 | $254 |
| Escitalopram Oxalate | 18 | $167 |
| Lorazepam | 33 | $148 |
| Quetiapine Fumarate | 32 | $146 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Reading
- Dennis BorczonErie$120K
- Suzanne LucotCranberry Township$72K
- Dan UdreaWexford$51K
- Robert WilsonErie$34K
- Craig FeasterState College$18K
- Thomas WindPhiladelphia$17K
- Laura AdangPhiladelphia$15K
- Christoph LamPhiladelphia$13K
- Raman BawejaHershey$11K
- Jeffrey HermannYork$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.